clopenthixol has been researched along with Dementia Praecox in 141 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 76 (53.90) | 18.7374 |
| 1990's | 20 (14.18) | 18.2507 |
| 2000's | 27 (19.15) | 29.6817 |
| 2010's | 16 (11.35) | 24.3611 |
| 2020's | 2 (1.42) | 2.80 |
| Authors | Studies |
|---|---|
| Høiseth, G; Molden, E; Smith, RL; Tveito, M | 1 |
| Barbui, C; Bertolini, F; Bovo, C; Correll, CU; Del Giovane, C; Gastaldon, C; Nosé, M; Ogheri, F; Ostuzzi, G; Papola, D; Purgato, M; Tedeschi, F; Turrini, G | 1 |
| Bryan, EJ; Kumar, A; Purcell, MA | 1 |
| Niederhofer, H | 1 |
| Al-Balushi, N; Harding, D; Mirza, H | 1 |
| Herath, U; Krishna, A; Pantelis, C; Thomas, N | 1 |
| Goujon, MJ; Murray, GK; Osimo, EF; Perez, J | 1 |
| Pischinger, B; Rosenleitner, J; Yazdi, K | 1 |
| Dejanović, SD; Janjić, V; Janković, S; Laban, O; Loncar, D; Milovanović, DR; Obradović, S; Stepanović, M; Varjaric, M; Zecević, DR | 1 |
| Aguirre, C; Albeniz, JM; Echaburu, SD; García, MG; Hernandez, R; Lertxundi, U; Ruiz, B | 1 |
| Jayaram, MB; Lacey, M | 1 |
| Hall, K; Lewitt, M; Melkersson, K | 1 |
| Allerup, PN; Ebdrup, BH; Fagerlund, B; Friberg, L; Glenthøj, BY; Nørbak-Emig, H; Pinborg, LH; Rasmussen, H; Rostrup, E; Svarer, C | 1 |
| Castle, DJ; Isik, T; Karagianis, J; Kim, CY; Melamed, Y; Omar, AN; Pidrman, V; Rosales, JI; Sarosi, A; Treuer, T; Udristoiu, T | 1 |
| Kumar, A; Strech, D | 2 |
| Altindag, A; Bulut, M; Dalkilic, A; Savas, HA; Virit, O | 1 |
| Aker, AT; Bos Gelmez, SÜ; Cerit, C; Ozten, E; Vural, M; Yıldız, M | 1 |
| Lam, D; Patten, SB; Pringsheim, T; Tano, DS | 1 |
| Gibson, RC; Gunadasa, S; Jayakody, K; Kumar, A | 1 |
| Sun, J; Xu, H; Zhao, Z | 1 |
| Andole, SN | 1 |
| Glenthoj, BY; Kristiansen, KT; Mackeprang, T | 1 |
| Bilici, M; Cakirbay, H; Guler, M; Tan, U; Tosun, M; Ulgen, M | 1 |
| Bellgrove, MA; Bradshaw, JL; Vance, A | 1 |
| BJORN, S; RASMUSSEN, C | 2 |
| BARTOVA, D; NAHUNEK, K; RODOVA, A; TOVAREK, J | 1 |
| POELDINGER, W | 2 |
| TEJMAR, J; VINAR, O; VINAROVA, M | 1 |
| HEIJBEL, J | 1 |
| Ravn, J | 1 |
| NUYTS, SA; SCHUNZELAAR, K; SEGERS, J | 1 |
| NOECKER, G | 1 |
| Fagerlund, B; Gade, A; Glenthøj, BY; Mackeprang, T | 1 |
| Eerdekens, E; Eerdekens, M; Jacko, M; Turner, M | 1 |
| Campbell, C; Coutinho, ES; Fenton, M; Gibson, RC | 1 |
| Bäumer, D; Ebert, D; Tebartz van Elst, L; Trimble, MR | 1 |
| Buschman, HP; Hariz, M; Kölling, P; Lenders, MW; Steur, EN; Vergouwen, MD | 1 |
| Chan, TY; Kwok, JS | 1 |
| Perquin, LN | 1 |
| Arango, C; Bobes, J; Bombín, I; García-Cabeza, I; González-Salvador, T | 1 |
| Rasmussen, K; Renkel, S | 1 |
| Glick, ID; Schreiner, A; Shkedy, Z | 1 |
| Alamo, C; Jiménez-Arriero, MA; López-Muñoz, F; Martínez, I; Ponce, G; Rubio, G | 1 |
| Cubała, WJ; Landowski, J; Wichowicz, HM | 1 |
| Baaré, WF; Glenthoj, A; Glenthoj, BY; Hemmingsen, RP; Jernigan, TL; Mackeprang, T; Pagsberg, AK | 1 |
| Aksoy, A; Ates, O; Deniz, O; Gundogdu, OL; Varoglu, AO | 1 |
| Dencker, SJ; Lepp, M; Malm, U | 3 |
| Carney, MW; Rutherford, P | 1 |
| Walker, CA | 1 |
| Ba, B; Berda, C; D'Agostino, N; Dufour, H; Durand, A; Hou, N; Jørgensen, A; Viala, A | 1 |
| Cesková, E; Náhunek, K; Rysánek, R; Svestka, J | 1 |
| Beccaceci, A; Borsetti, G; Cisternino, M; Frangiamone, L; Giavedoni, A; Judice, A; Rocco, P; Spilimbergo, PG; Volterra, V | 1 |
| Carney, MW | 1 |
| Hertrich, O | 1 |
| Dencker, SJ; Frankenberg, K; Hansen, V; Malm, U | 1 |
| Jrgensen, A; Overø, KF | 1 |
| Dencker, SJ; Jørgensen, A; Malm, U; Overø, KF | 1 |
| Overø, KF | 1 |
| Caillard, V; Cuche, H; Deniker, P; Sechter, D | 1 |
| Aaes-Jørgensen, T; Gravem, A; Jørgensen, A | 1 |
| Dencker, SJ; Elgen, K | 1 |
| Ahlfors, UG; Dencker, SJ; Gravem, A; Remvig, J | 1 |
| Bugge, A; Gravem, A | 1 |
| Heikkilä, L; Karsten, D; Valli, K | 1 |
| Heikkilä, L; Laitinen, J; Vartiainen, H | 1 |
| Rajhkowa, S; Viswanathan, R | 1 |
| Sieberns, S; Spechtmeyer, H | 1 |
| Huttunen, MO; Larmo, I; Nyholm, R; Piepponen, T; Raitasuo, V; Rantanen, H | 1 |
| Aitken, P; Bolton, J | 1 |
| Coupland, N; Nutt, O | 1 |
| O'Brien, J; Williams, J | 1 |
| Kjølbye, M; Olesen, OV; Rehfelt, E; Rogne, T; Thomsen, K | 1 |
| Beauclair, L; Chouinard, G; Safadi, G | 1 |
| Hamlin, GW; Ormerod, LP; Parry, AK; Saleem, PT | 1 |
| Bucci, P; Galderisi, S; Kemali, D; Maj, M; Mucci, A | 1 |
| Aaes-Jørgensen, T; Gerlach, J; Kistrup, K; Solgaard, T | 1 |
| Heikkilä, L | 1 |
| Khoo, YM; Lee, HS; Low, BL; Ng, LL; Tan, CH | 1 |
| Kropman, RF; Meinhardt, W; Moehadjir, D; van Hemert, AM | 1 |
| Gerlach, J; Larsen, EB | 1 |
| Dernovsek, MZ; Tavcar, R | 1 |
| Campbell, C; Coutinho, ES; Fenton, M | 2 |
| Coutinho, E; Fenton, M; Quraishi, S | 1 |
| Caraco, Y; Gural, A; Hirshberg, B | 1 |
| Chandramohan, P; Cheah, YC; Chin, CN; Hamid, AR; Leonard, AO; Loh, CC; Mahmud, M; Norhamidah, MS; Philip, G; Ramlee, T; Roslan, KA; Suraya, Y; Zakariah, MS; Zulkifli, G | 1 |
| Adams, C; Campbell, C; Coutinho, E; Fenton, M | 1 |
| Dahl, ML; Jaanson, P; Kiivet, RA; Marandi, T; Svensson, JO; Vään, S; Vasar, V | 1 |
| Gründig, E; Weiss, J | 1 |
| Ban, TA; Climan, M; Lehmann, HE; Sterlin, C | 1 |
| Baro, F; De Mesmaecker, L; Dom, R; van den Broucke, M; van Hest, T | 1 |
| Engstrand, E; Gravem, A; Guleng, RJ | 1 |
| Korsgaard, S; Skausig, OB | 1 |
| Unterrassner, R; Zmorski, T | 1 |
| Meyer, H; Reisecker, F; Tahedl, A; Weiser, G | 1 |
| de Boer, C; Gaete, HP | 1 |
| Koskinen, T; Mølbjerg, C; Nerdrum, T; Pedersen, V; Thelander, S; Wistedt, B | 1 |
| Heikkilä, L; Rimón, R; Terenius, L | 1 |
| Bertilsson, L; Dahl, ML; Ekqvist, B; Widén, J | 1 |
| Burrell, MF; Cashman, M; Fewster, C; Szabadi, E | 1 |
| Rogers, DG | 1 |
| Aaes-Jørgensen, T | 1 |
| Knudsen, P | 1 |
| Clayton, AR; Mann, BS; Moslehuddin, KS; Owen, RT; Rohatgi, KK; Sud, P; Vaddadi, KS | 1 |
| Aaes-Jørgensen, T; Amthor, KF; Baastrup, PC; Buckhave, J; Dencker, SJ; Gram, LF; Gravem, A; Jørgensen, A; Rosell, I | 1 |
| Lipska, B; Nurowska, K; Szukalski, B; Welbel, L | 1 |
| Ba, B; Durand, A; Gouezo, F; Hou, N; Jørgensen, A; Viala, A | 1 |
| Bhattacharyya, SN; Ghoshal, J; Halstead, N; John, B; Launer, MA; Mukherjee, PK; Sharma, SK; Zigmond, AS | 1 |
| Kazi, HA | 1 |
| Balon, R; Kabes, J; Papezová, H | 1 |
| Eberhardt, G; König, P; Seifert, T | 1 |
| Hansen, V; Ravn, J; Rud, C | 1 |
| Rimestad, S | 1 |
| Clark, ML; Collins, S; Serafetinides, EA | 1 |
| Clark, ML; Serafetinides, EA; Willis, D | 1 |
| Huvelle, R; Lhoas, JP; Meyers, C | 1 |
| Angus, JW; Arengo, AD; Beckles, ED; Rochlin, D; Simpson, GM | 1 |
| Clark, ML; Serafetinides, EA | 1 |
| Akpinar, S; Arat, M; Itil, TM; Saletu, B | 1 |
| Ban, TA; Jarrold, L; Sterlin, C | 1 |
| Serafetinides, EA | 1 |
| Serafetinides, EA; Willis, D | 1 |
| Merlis, S; Sheppard, C; Wolpert, A | 1 |
| Georgas, JG; Kazamias, NG; Kordas, SK; Papadokostakis, JG | 1 |
| Bastecký, J; Formánková, M; Růzicka, S; Taussigová, D; Vinar, O | 1 |
| Ban, TA; Bartolucci, G; Lee, H; Lehmann, HE | 1 |
| Dehnel, LL; Schiele, BC; Vestre, ND | 1 |
| Bishop, MP; Gallant, DM; Shelton, WH | 1 |
| Agola, P; Merlis, S; White, L; Wolpert, A; Yaryura-Tobias, JA | 1 |
| Amdisen, A; Gundersen, HJ | 1 |
| Harder, A; Modestin, J; Steiner, H | 1 |
| Kontsevoi, VA; Panteleeva, GP; Zavidovskaia, GI | 1 |
| Rapp, W | 1 |
| Bergonzi, P; Costa, P; Urbani, M | 1 |
| Alnaes, R | 1 |
| Haugan, S | 1 |
10 review(s) available for clopenthixol and Dementia Praecox
| Article | Year |
|---|---|
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis.
Topics: Antipsychotic Agents; Aripiprazole; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Patient Acceptance of Health Care; Phenothiazines; Psychotic Disorders; Risperidone; Schizophrenia; Secondary Prevention | 2021 |
Zuclopenthixol dihydrochloride for schizophrenia.
Topics: Antipsychotic Agents; Clopenthixol; Humans; Movement Disorders; Randomized Controlled Trials as Topic; Schizophrenia | 2017 |
Zuclopenthixol versus placebo for schizophrenia.
Topics: Antipsychotic Agents; Clopenthixol; Humans; Randomized Controlled Trials as Topic; Schizophrenia | 2015 |
Zuclopenthixol dihydrochloride for schizophrenia.
Topics: Antipsychotic Agents; Clopenthixol; Dyskinesia, Drug-Induced; Humans; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2009 |
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.
Topics: Acute Disease; Aggression; Antipsychotic Agents; Benzodiazepines; Clopenthixol; Dibenzothiazepines; Haloperidol; Humans; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Violence | 2012 |
Zuclopenthixol acetate for acute schizophrenia and similar serious mental illnesses.
Topics: Acute Disease; Antipsychotic Agents; Clopenthixol; Humans; Psychotic Disorders; Schizophrenia | 2004 |
Zuclopenthixol dihydrochloride for schizophrenia.
Topics: Antipsychotic Agents; Clopenthixol; Humans; Movement Disorders; Randomized Controlled Trials as Topic; Schizophrenia | 2005 |
Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses.
Topics: Acute Disease; Antipsychotic Agents; Clopenthixol; Humans; Psychotic Disorders; Schizophrenia | 2000 |
Zuclopenthixol decanoate for schizophrenia and other serious mental illnesses.
Topics: Administration, Oral; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Humans; Psychotic Disorders; Schizophrenia | 2000 |
Zuclopenthixol acetate in the treatment of acute schizophrenia and similar serious mental illnesses.
Topics: Acute Disease; Antipsychotic Agents; Clopenthixol; Humans; Psychotic Disorders; Schizophrenia | 2001 |
39 trial(s) available for clopenthixol and Dementia Praecox
| Article | Year |
|---|---|
Frontal D2/3 Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology.
Topics: Adult; Antipsychotic Agents; Attention; Clopenthixol; Cognition; Denmark; Dopamine Antagonists; Female; Frontal Lobe; Humans; Magnetic Resonance Imaging; Male; Molecular Imaging; Receptors, Dopamine D2; Receptors, Dopamine D3; Risperidone; Schizophrenia; Schizophrenic Psychology; Time Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Young Adult | 2016 |
Effects of antipsychotics on prepulse inhibition of the startle response in drug-naïve schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Female; Follow-Up Studies; Habituation, Psychophysiologic; Humans; Longitudinal Studies; Male; Neural Inhibition; Reflex, Startle; Risperidone; Schizophrenia | 2002 |
Classical and atypical neuroleptics, and bone mineral density, in patients with schizophrenia.
Topics: Adult; Analysis of Variance; Antipsychotic Agents; Benzodiazepines; Bone Density; Clopenthixol; Clozapine; Female; Fluphenazine; Haloperidol; Humans; Male; Olanzapine; Pirenzepine; Risperidone; Schizophrenia | 2002 |
Effects of low-dose risperidone and low-dose zuclopenthixol on cognitive functions in first-episode drug-naive schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Cognition; Dose-Response Relationship, Drug; Female; Humans; Male; Risperidone; Schizophrenia | 2004 |
Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Flupenthixol; Fluphenazine; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Movement Disorders; Psychiatric Status Rating Scales; Risperidone; Schizophrenia | 2004 |
Randomised clinical trial comparing oral versus depot formulations of zuclopenthixol in patients with schizophrenia and previous violence.
Topics: Administration, Oral; Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Female; Humans; Male; Prospective Studies; Schizophrenia; Violence | 2006 |
Differential early onset of therapeutic response with risperidone vs conventional antipsychotics in patients with chronic schizophrenia.
Topics: Antipsychotic Agents; Chronic Disease; Clopenthixol; Double-Blind Method; Female; Haloperidol; Humans; Male; Perphenazine; Risperidone; Schizophrenia; Treatment Outcome | 2006 |
Long-acting injectable risperidone compared with zuclopenthixol in the treatment of schizophrenia with substance abuse comorbidity.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Clopenthixol; Comorbidity; Delayed-Action Preparations; Double-Blind Method; Female; Follow-Up Studies; Humans; Injections, Intravenous; Male; Middle Aged; Risperidone; Schizophrenia; Substance-Related Disorders | 2006 |
Basal ganglia volumes in drug-naive first-episode schizophrenia patients before and after short-term treatment with either a typical or an atypical antipsychotic drug.
Topics: Adult; Antipsychotic Agents; Basal Ganglia; Caudate Nucleus; Cholinergic Antagonists; Clopenthixol; Drug Administration Schedule; Female; Functional Laterality; Globus Pallidus; Humans; Magnetic Resonance Imaging; Male; Nucleus Accumbens; Putamen; Risperidone; Schizophrenia; Time Factors | 2007 |
A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
Topics: Antipsychotic Agents; Chronic Disease; Clinical Trials as Topic; Clopenthixol; Delayed-Action Preparations; Double-Blind Method; Fluphenazine; Humans; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes | 1983 |
Blood and plasma kinetics of cis(Z)-clopenthixol and fluphenazine in psychiatric patients after intramuscular injection of their decanoic esters.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Fluphenazine; Humans; Injections, Intramuscular; Kinetics; Male; Middle Aged; Radioimmunoassay; Schizophrenia; Thioxanthenes | 1984 |
Aspects of clinical psychiatric research on depot neuroleptics. The presentation of two double-blind trials with cis(z)-clopenthixol decanoate and a withdrawal study in schizophrenics.
Topics: Clinical Trials as Topic; Clopenthixol; Delayed-Action Preparations; Double-Blind Method; Humans; Psychiatric Status Rating Scales; Schizophrenia; Substance Withdrawal Syndrome; Thioxanthenes | 1980 |
Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Clopenthixol; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Patient Dropouts; Perphenazine; Psychiatric Status Rating Scales; Scandinavian and Nordic Countries; Schizophrenia; Thioxanthenes | 1980 |
Cis(Z)-clopenthixol and clopenthixol in the treatment of acute psychoses and exacerbations of chronic psychoses. A double-blind clinical investigation.
Topics: Adult; Aged; Clinical Trials as Topic; Clopenthixol; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Stereoisomerism; Thioxanthenes | 1981 |
A double-blind clinical investigation of cis(Z)-clopenthixol and clopenthixol in chronic schizophrenic patients.
Topics: Adult; Aged; Clinical Trials as Topic; Clopenthixol; Double-Blind Method; Female; Humans; Intellectual Disability; Male; Middle Aged; Schizophrenia; Stereoisomerism; Thioxanthenes | 1981 |
Cis(Z)-clopenthixol and haloperidol in chronic schizophrenic patients--a double-blind clinical multicentre investigation.
Topics: Adult; Clinical Trials as Topic; Clopenthixol; Double-Blind Method; Female; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Stereoisomerism; Thinking; Thioxanthenes | 1981 |
Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: a double-blind parallel-group trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Antipsychotic Agents; Clopenthixol; Double-Blind Method; Female; Humans; Isoxazoles; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology | 1995 |
Search for a therapeutic range for serum zuclopenthixol concentrations in schizophrenic patients.
Topics: Adult; Aged; Chronic Disease; Clopenthixol; Denmark; Drug Monitoring; Female; Humans; Male; Middle Aged; Schizophrenia; Time Factors | 1994 |
A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Arousal; Clopenthixol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Neurologic Examination; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1994 |
Zuclopenthixol decanoate in maintenance treatment of schizophrenic outpatients. Minimum effective dose and corresponding serum levels.
Topics: Adult; Aged; Clopenthixol; Female; Humans; Male; Middle Aged; Outpatients; Schizophrenia | 1994 |
A double blind comparison of zuclopenthixol acetate with haloperidol in the management of acutely disturbed schizophrenics.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Double-Blind Method; Female; Haloperidol; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1998 |
Comprehesiven clinical studies with thiothixene.
Topics: Adolescent; Adult; Aged; Chlorpromazine; Clinical Trials as Topic; Clopenthixol; Drug Evaluation; Female; Humans; Male; Mental Disorders; Middle Aged; Phenothiazines; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Thiothixene | 1975 |
Maintenance treatment of chronic schizophrenic patients. A study with the long-acting thioxanthene derivative, cis(Z)-clopenthixol decanoate-sordinol depot.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Clopenthixol; Delayed-Action Preparations; Drug Evaluation; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes | 1978 |
Cis(Z)-clopenthixol and clopenthixol (Sordinol) in chronic psychotic patients. A double-blind clinical investigation.
Topics: Adult; Aged; Clinical Trials as Topic; Clopenthixol; Double-Blind Method; Drug Evaluation; Female; Humans; Male; Middle Aged; Schizophrenia; Stereoisomerism; Thioxanthenes | 1978 |
Zuclopenthixol decanoate and haloperidol decanoate in chronic schizophrenia: a double-blind multicentre study.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Clopenthixol; Double-Blind Method; Female; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Severity of Illness Index; Sex Factors | 1991 |
Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia. Chemically unrelated antipsychotics as therapeutic alternatives.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Analysis of Variance; Bilirubin; Blood Cell Count; Blood Pressure; Blood Urea Nitrogen; Body Temperature; Body Weight; Chemical and Drug Induced Liver Injury; Chlorpromazine; Cholesterol; Chronic Disease; Clinical Trials as Topic; Clopenthixol; Extrapyramidal Tracts; Female; Haloperidol; Hematocrit; Humans; Liver; Male; Middle Aged; Piperazines; Placebos; Psychiatric Status Rating Scales; Psychological Tests; Schizophrenia; Tranquilizing Agents; Xanthenes | 1972 |
Haloperidol, clopenthixol, and chlorpromazine in chronic schizophrenia.
Topics: Adult; Chlorpromazine; Chronic Disease; Clinical Trials as Topic; Clopenthixol; Electroencephalography; Evaluation Studies as Topic; Female; Haloperidol; Humans; Male; Middle Aged; Placebos; Schizophrenia; Tranquilizing Agents | 1972 |
[Rediscovery of a neuroleptic drug in a new form: clopenthixol].
Topics: Aged; Clinical Trials as Topic; Clopenthixol; Dementia; Evaluation Studies as Topic; Humans; Middle Aged; Piperazines; Schizophrenia; Tranquilizing Agents; Xanthenes | 1972 |
A one-year trial of clopenthixol in chronic schizophrenia.
Topics: Adult; Chronic Disease; Clinical Trials as Topic; Clopenthixol; Female; Humans; Male; Middle Aged; Piperazines; Schizophrenia; Tranquilizing Agents; Xanthenes | 1972 |
Psychological effects of single-dose antipsychotic medication.
Topics: Adult; Chlorpromazine; Clinical Trials as Topic; Clopenthixol; Dose-Response Relationship, Drug; Female; Haloperidol; Humans; Male; Middle Aged; Motor Skills; Piperazines; Placebos; Psychological Tests; Schizophrenia; Thioxanthenes; Tranquilizing Agents; Xanthenes | 1973 |
Long-term clinical and quantitative EEG effects of clopenthixol in schizophrenics: clinical-neurophysiological correlations.
Topics: Adult; Analysis of Variance; Blood Pressure; Body Weight; Clinical Trials as Topic; Clopenthixol; Computers; Electroencephalography; Female; Heart Rate; Humans; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes; Time Factors; Tranquilizing Agents | 1973 |
The place of thiothixene among the thioxanthenes.
Topics: Acute Disease; Adolescent; Adult; Central Nervous System; Chlorprothixene; Chronic Disease; Clinical Trials as Topic; Clopenthixol; Evaluation Studies as Topic; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thiothixene; Tranquilizing Agents; Xanthenes | 1972 |
A method of quantifying EEG for psychopharmacological research.
Topics: Alpha Rhythm; Chlorpromazine; Clopenthixol; Electroencephalography; Haloperidol; Humans; Methods; Molindone; Placebos; Psychiatric Status Rating Scales; Psychopharmacology; Research; Schizophrenia | 1973 |
An early clinical evaluation of clopenthixol in treatment-resistant female schizophrenic patients.
Topics: Adult; Clinical Trials as Topic; Clopenthixol; Female; Humans; Middle Aged; Schizophrenia; Tranquilizing Agents | 1967 |
Clopenthixol: a controlled trial in chronic hospitalized schizophrenic patients.
Topics: Adult; Analysis of Variance; Behavior; Chlorpromazine; Clinical Trials as Topic; Clopenthixol; Female; Humans; Male; Menstruation; Middle Aged; Piperazines; Placebos; Psychological Tests; Schizophrenia; Tranquilizing Agents; Xanthenes | 1968 |
Clopenthixol in schizophrenia. Comparison of two groups of patients treated by the same drug.
Topics: Adolescent; Adult; Aged; Clinical Trials as Topic; Clopenthixol; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Tranquilizing Agents; Xanthenes | 1967 |
A controlled comparison of clopenthixol and perphenazine in a chronic schizophrenic population.
Topics: Adult; Animals; Clopenthixol; Humans; Male; Middle Aged; Perphenazine; Piperazines; Schizophrenia; Tranquilizing Agents; Xanthenes | 1968 |
The Achilles reflex and antipsychotic drugs.
Topics: Achilles Tendon; Adult; Clinical Trials as Topic; Clopenthixol; Female; Humans; Male; Middle Aged; Piperazines; Reflex, Stretch; Schizophrenia; Tranquilizing Agents; Trifluoperazine; Xanthenes | 1969 |
A clinical evaluation of clopenthixol.
Topics: Adult; Clinical Trials as Topic; Clopenthixol; Female; Hallucinations; Humans; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Schizophrenia; Tranquilizing Agents; Xanthenes | 1970 |
92 other study(ies) available for clopenthixol and Dementia Praecox
| Article | Year |
|---|---|
Impact of age and CYP2D6 genotype on exposure of zuclopenthixol in patients using long-acting injectable versus oral formulation-an observational study including 2044 patients.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antipsychotic Agents; Clopenthixol; Cytochrome P-450 CYP2D6; Delayed-Action Preparations; Female; Humans; Injections; Male; Middle Aged; Norway; Pharmacogenomic Variants; Retrospective Studies; Schizophrenia; Young Adult | 2021 |
Tizanidine is not effective treating EPMS.
Topics: Adolescent; Adult; Basal Ganglia Diseases; Biperiden; Cholinergic Antagonists; Clonidine; Clopenthixol; Female; Humans; Movement Disorders; Schizophrenia; Treatment Outcome | 2018 |
Paliperidone Palmitate-Induced Delirium in an Adolescent with Schizophrenia: Case report.
Topics: Activities of Daily Living; Adolescent; Antipsychotic Agents; Clopenthixol; Delirium; Drug Substitution; Humans; Male; Medication Adherence; Paliperidone Palmitate; Schizophrenia | 2018 |
Electroencephalography identifies encephalopathy associated with adjunctive lithium and zuclopenthixol.
Topics: Antipsychotic Agents; Brain; Clopenthixol; Drug Therapy, Combination; Electroconvulsive Therapy; Electroencephalography; Humans; Lithium; Male; Middle Aged; Neurotoxicity Syndromes; Schizophrenia | 2019 |
Can typical and atypical antipsychotics show differential effectiveness in treating paranoia and hallucinations in schizophrenia?
Topics: Adult; Antipsychotic Agents; Clopenthixol; Dopamine Antagonists; Drug Therapy, Combination; Hallucinations; Humans; Male; Olanzapine; Paranoid Disorders; Receptors, Dopamine; Schizophrenia; Treatment Outcome | 2019 |
[Combination of two depot antipsychotic drugs].
Topics: Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Drug Therapy, Combination; Female; Humans; Risperidone; Schizophrenia; Treatment Outcome | 2014 |
Zuclopenthixol decanoate in pregnancy: successful outcomes in two consecutive offsprings of the same mother.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Female; Humans; Infant, Newborn; Male; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Schizophrenia | 2013 |
Possible interaction between letrozole and long-acting injectable zuclopenthixol.
Topics: Aged; Antineoplastic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Clopenthixol; Dibenzothiazepines; Drug Interactions; Female; Humans; Letrozole; Nitriles; Quetiapine Fumarate; Schizophrenia; Triazoles | 2015 |
Higher serum concentrations of tyrosine and glutamate in schizophrenia patients treated with clozapine, compared to in those treated with conventional antipsychotics.
Topics: Adult; Amino Acids; Antipsychotic Agents; Chromatography, Ion Exchange; Clopenthixol; Clozapine; Cohort Studies; Female; Glutamic Acid; Haloperidol; Humans; Insulin Resistance; Male; Middle Aged; Perphenazine; Prospective Studies; Psychotic Disorders; Schizophrenia; Thioridazine; Tyrosine | 2015 |
Intramuscular olanzapine versus short-acting typical intramuscular antipsychotics: comparison of real-life effectiveness in the treatment of agitation.
Topics: Acute Disease; Administration, Oral; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Bipolar Disorder; Clopenthixol; Cross-Cultural Comparison; Female; Haloperidol; Hospitalization; Humans; Injections, Intramuscular; Male; Olanzapine; Psychiatric Status Rating Scales; Psychomotor Agitation; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2009 |
Beneficial effects of N-acetylcysteine in treatment resistant schizophrenia.
Topics: Acetylcysteine; Adult; Antipsychotic Agents; Benzodiazepines; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Free Radical Scavengers; Humans; Olanzapine; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 2009 |
Metabolic syndrome with different antipsychotics: a multicentre cross-sectional study.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Chi-Square Distribution; Clopenthixol; Clozapine; Cross-Sectional Studies; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Olanzapine; Prevalence; Risk Assessment; Risk Factors; Risperidone; Schizophrenia; Turkey; Young Adult | 2010 |
The pharmacoepidemiology of antipsychotics for adults with schizophrenia in Canada, 2005 to 2009.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Canada; Chlorpromazine; Clopenthixol; Clozapine; Female; Flupenthixol; Humans; Loxapine; Male; Olanzapine; Pharmacoepidemiology; Schizophrenia | 2011 |
Network-assisted investigation of antipsychotic drugs and their targets.
Topics: Antipsychotic Agents; Clopenthixol; Databases, Factual; Drug Interactions; Gene Regulatory Networks; Humans; Piperazines; Schizophrenia; Thiazoles; Thiothixene | 2012 |
An unusual presentation of cortical venous thrombosis and its association with typical antipsychotics.
Topics: Adult; Anticoagulants; Antipsychotic Agents; Cerebral Veins; Clopenthixol; Heparin; Humans; Magnetic Resonance Imaging; Male; Schizophrenia; Venous Thrombosis; Warfarin | 2011 |
Local-global processing in early-onset schizophrenia: evidence for an impairment in shifting the spatial scale of attention.
Topics: Adolescent; Affect; Antipsychotic Agents; Attention; Benzodiazepines; Clopenthixol; Diazepam; Female; Flupenthixol; Frontal Lobe; Humans; Male; Olanzapine; Parietal Lobe; Perceptual Disorders; Pirenzepine; Reaction Time; Risperidone; Schizophrenia; Space Perception; Time Factors | 2003 |
[Clopenthixol (Sordinol) in treatment of schizophrenic patients].
Topics: Clopenthixol; Humans; Schizophrenia; Tranquilizing Agents | 1963 |
[CLINICAL EXPERIENCES WITH THE THIOXANTHENE DERIVATIVE, SORDINOL].
Topics: Clopenthixol; Humans; Schizophrenia; Tranquilizing Agents | 1963 |
[CLINICAL EXPERIENCES WITH THE THIAXANTHENE DERIVATIVE CLOPENTHIXOL (SORDINOL) IN PSYCHIATRIC PHARMACOTHERAPY].
Topics: Antisocial Personality Disorder; Clopenthixol; Depression; Humans; Intellectual Disability; Mental Disorders; Paranoid Disorders; Psychotic Disorders; Schizophrenia; Tranquilizing Agents | 1963 |
SORDINOL (CLOPENTHIXOL) IN THE TREATMENT OF SCHIZOPHRENICS.
Topics: Biomedical Research; Clopenthixol; Geriatrics; Humans; Schizophrenia; Statistics as Topic; Toxicology; Tranquilizing Agents | 1963 |
OUR FIRST EXPERIENCES WITH TIME-INTERVAL REPRODUCTION TEST IN PSYCHIATRY.
Topics: Bipolar Disorder; Clopenthixol; Drug Therapy; Humans; Mental Disorders; Psychiatry; Psychological Tests; Psychotic Disorders; Schizophrenia; Time Perception; Tranquilizing Agents; Trifluoperazine | 1964 |
[DEMENTIA PRAECOCISSIMA].
Topics: Autistic Disorder; Brain; Brain Damage, Chronic; Catatonia; Child; Chlorpromazine; Clopenthixol; Dementia; Electroencephalography; Humans; Physiology; Schizophrenia; Schizophrenia, Childhood; Tranquilizing Agents | 1964 |
LETTER TO THE EDITOR: SORDINOL(CLOPENTHIXOL) IN THE TREATMENT OF SCHIZOPHRENICS.
Topics: Clopenthixol; Drug Therapy; Humans; Pharmacology; Schizophrenia; Toxicology; Tranquilizing Agents | 1964 |
REPORT ON THE TREATMENT OF PSYCHOTIC PATIENTS WITH SORDINOL.
Topics: Adolescent; Clopenthixol; Humans; Imipramine; Parkinsonian Disorders; Psychotic Disorders; Schizophrenia; Thiazines; Toxicology; Tranquilizing Agents | 1964 |
[CLOPENTHIXOL (CIATYL). NEUROLEPTIC EFFECT WITH SPECIAL REFERENCE TO EXTRAPYRAMIDAL SYMPTOMS].
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Clopenthixol; Drug Therapy; Movement Disorders; Schizophrenia; Toxicology; Tranquilizing Agents | 1964 |
Chronic antidopaminergic medication might affect amygdala structure in patients with schizophrenia.
Topics: Amygdala; Antipsychotic Agents; Brain; Clopenthixol; Dose-Response Relationship, Drug; Epilepsy, Temporal Lobe; Factor Analysis, Statistical; Flupenthixol; Haloperidol; Hippocampus; Humans; Psychotic Disorders; Risperidone; Schizophrenia; Trifluoperazine | 2004 |
Long term results of unilateral posteroventral pallidotomy for antipsychotic drug induced tardive dyskinesia.
Topics: Athetosis; Chorea; Clopenthixol; Delayed-Action Preparations; Dominance, Cerebral; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Follow-Up Studies; Globus Pallidus; Haloperidol; Humans; Male; Middle Aged; Myoclonus; Neurologic Examination; Outcome Assessment, Health Care; Schizophrenia; Treatment Outcome | 2005 |
Recurrent heat-related illnesses during antipsychotic treatment.
Topics: Antipsychotic Agents; Body Temperature Regulation; Chlorpromazine; Clopenthixol; Diabetes Complications; Heat Exhaustion; Heat Stroke; Humans; Male; Middle Aged; Muscarinic Antagonists; Recurrence; Schizophrenia; Trihexyphenidyl | 2005 |
Treatment with the new antipsychotic sertindole for late-occurring undesirable movement effects.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Clopenthixol; Female; Haloperidol; Humans; Imidazoles; Indoles; Male; Middle Aged; Schizophrenia; Time Factors | 2005 |
Antipsychotic medication and length of stay at a psychiatric maximum-security unit in Norway (1987-2000).
Topics: Adult; Aged; Antipsychotic Agents; Clopenthixol; Female; Hospitalization; Humans; Length of Stay; Male; Maximum Tolerated Dose; Middle Aged; Norway; Psychiatric Department, Hospital; Schizophrenia; Schizophrenic Psychology; Time Factors; Violence | 2006 |
Refractory schizophrenia treated with clozapine combined with zuclopenthixol.
Topics: Antipsychotic Agents; Clopenthixol; Clozapine; Drug Therapy, Combination; Humans; Schizophrenia | 2007 |
Zuclopenthixol-induced neuroleptic malignant syndrome presenting as fever of unknown origin, hyperglycaemia and acute myocardial infarction in a 60-year-old man.
Topics: Antipsychotic Agents; Clopenthixol; Creatine Kinase; Delayed-Action Preparations; Diagnosis, Differential; Fatal Outcome; Fever of Unknown Origin; Humans; Hyperglycemia; Injections, Intramuscular; Male; Middle Aged; Myocardial Infarction; Neuroleptic Malignant Syndrome; Schizophrenia; Shock, Cardiogenic | 2009 |
Do schizophrenics well adapted in the community need neuroleptics? A depot neuroleptic withdrawal study.
Topics: Ambulatory Care; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Follow-Up Studies; Humans; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Social Adjustment; Substance Withdrawal Syndrome; Time Factors | 1980 |
Clopenthixol decanoate in schizophrenia.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Thioxanthenes | 1981 |
[A 1-year experience with the administration of clopenthixol decanoate in schizophrenic psychoses].
Topics: Adult; Antipsychotic Agents; Clopenthixol; Female; Humans; Male; Schizophrenia; Thioxanthenes | 1984 |
Long-term treatment of chronic schizophrenics with clopenthixol decanoate.
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Clopenthixol; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes; Time Factors | 1984 |
A 5-year follow-up study of chronic schizophrenics treated with clopenthixol decanoate.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Chronic Disease; Clopenthixol; Female; Follow-Up Studies; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1984 |
[Ataractic treatment in psychiatry and general medicine. Overview of preparations, 3].
Topics: Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Benzodiazepinones; Chlorprothixene; Clobazam; Clomipramine; Clonazepam; Clopenthixol; Epilepsy; Humans; Schizophrenia; Tranquilizing Agents | 1983 |
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. I. A one year double-blind study of clopenthixol decanoate and flupenthixol palmitate.
Topics: Adult; Aged; Ambulatory Care; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Double-Blind Method; Drug Evaluation; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes; Time Factors | 1980 |
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. II. Factor analysis of the CPRS sub-scale for schizophrenia.
Topics: Adult; Aged; Ambulatory Care; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Drug Evaluation; Factor Analysis, Statistical; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes; Time Factors | 1980 |
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. III. Serum levels.
Topics: Ambulatory Care; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Half-Life; Humans; Injections, Intramuscular; Schizophrenia; Thioxanthenes; Time Factors | 1980 |
Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. IV. Serum levels and clinical outcome.
Topics: Ambulatory Care; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Flupenthixol; Humans; Prognosis; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes | 1980 |
A specific method for assay of drug levels in serum of patients treated with clopenthixol decanoate injections.
Topics: Clopenthixol; Delayed-Action Preparations; Fluorometry; Humans; Injections, Intramuscular; Schizophrenia; Thioxanthenes | 1980 |
Open clinical study of cis(Z)-clopenthixol.
Topics: Adult; Aged; Clopenthixol; Drug Evaluation; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Stereoisomerism; Thioxanthenes | 1981 |
Serum levels of the isomers of clopenthixol in patients given cis(Z)-clopenthixol or cis(Z)/trans(E)-clopenthixol.
Topics: Adult; Aged; Clopenthixol; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1981 |
Clopenthixol decanoate in the treatment of chronic schizophrenic in-patients.
Topics: Adult; Aged; Chronic Disease; Clopenthixol; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes; Time Factors | 1982 |
[cis(Z)-Clopenthixol decanoate--a new depot neuroleptic].
Topics: Chemical Phenomena; Chemistry; Clopenthixol; Delayed-Action Preparations; Humans; Kinetics; Schizophrenia; Thioxanthenes; Time Factors | 1982 |
Intramuscular injections in the anticoagulated state.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Contraindications; Heparin; Humans; Injections, Intramuscular; Male; Schizophrenia; Warfarin | 1995 |
Successful treatment of tardive oculogyric spasms with vitamin E.
Topics: Adult; Anti-Dyskinesia Agents; Antipsychotic Agents; Clopenthixol; Dyskinesia, Drug-Induced; Humans; Male; Schizophrenia; Vitamin E | 1995 |
Ejaculation associated with zuclopenthixol.
Topics: Adult; Clopenthixol; Depressive Disorder; Ejaculation; Humans; Male; Schizophrenia; Vas Deferens | 1994 |
Recurrent sinus arrest in association with neuroleptic malignant syndrome.
Topics: Adult; Antipsychotic Agents; Cardiac Pacing, Artificial; Catatonia; Chlorpromazine; Clopenthixol; Drug Therapy, Combination; Electrocardiography; Female; Haloperidol; Heart Arrest; Humans; Neuroleptic Malignant Syndrome; Neurologic Examination; Schizophrenia | 1994 |
QEEG alpha 1 changes after a single dose of high-potency neuroleptics as a predictor of short-term response to treatment in schizophrenic patients.
Topics: Adolescent; Adult; Brain; Clopenthixol; Dose-Response Relationship, Drug; Electroencephalography; Female; Haloperidol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Treatment Outcome | 1994 |
Somatostatin in the cerebrospinal fluid of schizophrenic patients before and after neuroleptic drug treatment.
Topics: Adult; Borderline Personality Disorder; Chronic Disease; Clopenthixol; Drug Therapy, Combination; Female; Humans; Lorazepam; Male; Middle Aged; Neurotic Disorders; Psychiatric Status Rating Scales; Psychotropic Drugs; Radioimmunoassay; Schizophrenia; Schizophrenic Psychology; Somatostatin | 1993 |
Clinical evaluation and serum concentration of zuclopenthixol acetate in psychotic Asian patients: a single-dose preliminary study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Bipolar Disorder; China; Clopenthixol; Female; Humans; India; Injections, Intramuscular; Malaysia; Male; Middle Aged; Psychotic Disorders; Schizophrenia; Singapore | 1993 |
Recurrent priapism as a side effect of zuclopenthixol decanoate.
Topics: Adult; Clopenthixol; Follow-Up Studies; Humans; Male; Priapism; Schizophrenia; Treatment Outcome | 1995 |
Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Flupenthixol; Humans; Male; Middle Aged; Neurologic Examination; Perphenazine; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Sick Role | 1996 |
Age at onset of schizophrenia and neuroleptic dosage.
Topics: Adult; Age of Onset; Antipsychotic Agents; Clopenthixol; Dose-Response Relationship, Drug; Female; Fluphenazine; Humans; Male; Schizophrenia; Slovenia | 1999 |
Zuclopenthixol-associated neutropenia and thrombocytopenia.
Topics: Aged; Antipsychotic Agents; Clopenthixol; Humans; Leukocyte Count; Male; Neutropenia; Platelet Count; Schizophrenia; Thrombocytopenia | 2000 |
Zuclopenthixol acetate in psychiatric emergencies: looking for evidence from clinical trials.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Clopenthixol; Emergency Services, Psychiatric; Humans; Middle Aged; Randomized Controlled Trials as Topic; Schizophrenia | 2000 |
Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype.
Topics: Adult; Aged; Analysis of Variance; Chi-Square Distribution; Clopenthixol; Confidence Intervals; Cytochrome P-450 CYP2D6; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Odds Ratio; Parkinsonian Disorders; Polymorphism, Genetic; Regression Analysis; Schizophrenia | 2002 |
[The influence of neuroleptic drugs on urinary excretion of non-protein nitrogen (author's transl)].
Topics: Amino Acids; Clopenthixol; Clozapine; Creatinine; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Humans; Hydrogen-Ion Concentration; Ion Exchange Resins; Nitrogen; Procyclidine; Schizophrenia; Thioridazine; Tranquilizing Agents; Urea | 1976 |
Increase in weight after treatment with depot neuroleptics.
Topics: Administration, Oral; Body Weight; Clopenthixol; Delayed-Action Preparations; Drug Implants; Female; Humans; Perphenazine; Schizophrenia; Thioxanthenes | 1979 |
[Clinical experience with Cis-(Z-)Clopenthixol-Decanoate (Sordinol-Depot) (author's transl)].
Topics: Adolescent; Adult; Clopenthixol; Decanoates; Decanoic Acids; Delayed-Action Preparations; Drug Evaluation; Female; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1979 |
[Advantages of the initial therapy of acute schizophrenia with large doses of droperidol/A comparative study (author's transl)].
Topics: Acute Disease; Biperiden; Blood Pressure; Clopenthixol; Clozapine; Droperidol; Drug Administration Schedule; Drug Evaluation; Humans; Male; Psychological Tests; Remission, Spontaneous; Salivation; Schizophrenia; Schizophrenic Psychology | 1975 |
Neuroleptic malignant syndrome and diabetic keto-acidosis.
Topics: Adult; Chlorpromazine; Clopenthixol; Diabetic Ketoacidosis; Drug Therapy, Combination; Humans; Male; Neuroleptic Malignant Syndrome; Schizophrenia | 1992 |
Dynorphin A and substance P in the cerebrospinal fluid of schizophrenic patients.
Topics: Adult; Clopenthixol; Dose-Response Relationship, Drug; Drug Administration Schedule; Dynorphins; Female; Humans; Male; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Substance P | 1990 |
Disposition of the neuroleptic zuclopenthixol cosegregates with the polymorphic hydroxylation of debrisoquine in humans.
Topics: Administration, Oral; Adult; Clopenthixol; Debrisoquin; Female; Humans; Hydroxylation; Male; Perphenazine; Schizophrenia | 1991 |
Clozapine-treated NMS.
Topics: Adult; Chlorpromazine; Clopenthixol; Clozapine; Drug Therapy, Combination; Humans; Male; Neuroleptic Malignant Syndrome; Procyclidine; Recurrence; Schizophrenia; Schizophrenic Psychology | 1991 |
Oculogyric crises and schizophrenia.
Topics: Adult; Clopenthixol; Dose-Response Relationship, Drug; Eye Movements; Female; Hallucinations; Humans; Schizophrenia; Schizophrenic Psychology; Thioxanthenes | 1989 |
Pharmacokinetics of three different injectable zuclopenthixol preparations.
Topics: Adult; Aged; Animals; Antipsychotic Agents; Clopenthixol; Dogs; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Psychotic Disorders; Reference Values; Schizophrenia; Thioxanthenes | 1989 |
Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations.
Topics: Administration, Oral; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Haloperidol; Humans; Kinetics; Long-Term Care; Patient Compliance; Perphenazine; Schizophrenia; Schizophrenic Psychology; Thiazines | 1985 |
A clinical assessment of zuclopenthixol dihydrochloride (Clopixol tablets) in the treatment of psychotic illness.
Topics: Adolescent; Adult; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Humans; Male; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Sex Factors; Thioxanthenes; Time Factors | 1985 |
Zuclopenthixol decanoate in schizophrenia: serum levels and clinical state.
Topics: Adult; Aged; Antipsychotic Agents; Clopenthixol; Female; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1985 |
Serum levels and clinical response in long-term pharmacotherapy with zuclopenthixol decanoate.
Topics: Adult; Basal Ganglia Diseases; Brief Psychiatric Rating Scale; Clopenthixol; Female; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1986 |
Comparative study of the pharmacokinetics of zuclopenthixol decanoate and fluphenazine decanoate.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Female; Fluphenazine; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes; Tranquilizing Agents | 1988 |
Acute functional psychoses: treatment with zuclopenthixol dihydrochloride ('Clopixol') tablets.
Topics: Acute Disease; Adult; Bipolar Disorder; Clopenthixol; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Tablets; Thioxanthenes | 1987 |
Schizophrenic relapse after drug withdrawal is predictable.
Topics: Adult; Aged; Clopenthixol; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Recurrence; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; Thioxanthenes | 1986 |
An open clinical trial with the long-acting neuroleptic zuclopenthixol decanoate in the maintenance treatment of schizophrenia.
Topics: Adult; Aged; Chronic Disease; Clopenthixol; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Thioxanthenes | 1986 |
[Maintenance therapy using clopenthixol decanoate in schizophrenic patients].
Topics: Adolescent; Adult; Clopenthixol; Female; Humans; Male; Middle Aged; Schizophrenia; Thioxanthenes | 1986 |
Findings with cis-Z-clopenthixol in the treatment of acute mania and schizophrenia.
Topics: Adult; Bipolar Disorder; Clopenthixol; Female; Flicker Fusion; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Stereoisomerism; Thioxanthenes | 1986 |
Long-term treatment of psychiatric patients with clopenthixol: analysis of laboratory tests with a view to long-term therapy.
Topics: Adult; Aged; Bipolar Disorder; Blood Cell Count; Clopenthixol; Creatinine; Female; Hematocrit; Humans; Intellectual Disability; Kidney Function Tests; Liver Function Tests; Middle Aged; Paresis; Psychotic Disorders; Schizophrenia; Time Factors; Tranquilizing Agents | 1974 |
Clinical physiognomy of chlorprothixene and clopentixol.
Topics: Adolescent; Adult; Bipolar Disorder; Child; Child Behavior Disorders; Child, Preschool; Chlorprothixene; Clopenthixol; Depression; Female; Humans; Male; Mental Disorders; Neurotic Disorders; Personality Disorders; Psychoses, Alcoholic; Schizophrenia; Thioxanthenes | 1974 |
Voltage laterality in the EEG of psychiatric patients.
Topics: Adult; Brain; Chlorpromazine; Clopenthixol; Dominance, Cerebral; Dose-Response Relationship, Drug; Electroencephalography; Female; Functional Laterality; Haloperidol; Humans; Male; Middle Aged; Schizophrenia; Tranquilizing Agents | 1973 |
Clinical studies with clopenthixol (sordinol) on chronic psychiatric patients.
Topics: Chlorprothixene; Clopenthixol; Female; Humans; Male; Perphenazine; Schizophrenia; Tranquilizing Agents | 1966 |
The electrophoretic pattern of alkaline phosphatase in schizophrenic females under long-term treatment with neuroleptic drugs and in young and old healthy women.
Topics: Adult; Age Factors; Aged; Alkaline Phosphatase; Blood Protein Electrophoresis; Chlorpromazine; Chlorprothixene; Clopenthixol; Electrophoresis; Female; Humans; Liver; Long-Term Care; Middle Aged; Perphenazine; Schizophrenia; Thioridazine; Tranquilizing Agents | 1969 |
[Course of body temperature during injection therapy with neuroleptics. Statistical evaluation of data from a retrospective study].
Topics: Body Temperature; Chlorpromazine; Chlorprothixene; Clopenthixol; Dibenzothiazepines; Electroconvulsive Therapy; Haloperidol; Humans; Mental Disorders; Methotrimeprazine; Parasympatholytics; Piperazines; Retrospective Studies; Schizophrenia; Tranquilizing Agents; Xanthines | 1971 |
[On the therapeutic effect of sordinol and fluanxol in the treatment of schizophrenic patients].
Topics: Adolescent; Adult; Clopenthixol; Ethanol; Humans; Middle Aged; Piperazines; Schizophrenia; Tranquilizing Agents | 1969 |
[Comparative clinical-psychiatric experiences with thiaxanthene-derivatives with special consideration of flupenthixol].
Topics: Adult; Chlorprothixene; Clopenthixol; Depression; Female; Humans; Male; Middle Aged; Movement Disorders; Oral Manifestations; Paranoid Disorders; Parasympatholytics; Piperazines; Schizophrenia; Tranquilizing Agents; Xanthenes | 1967 |
[Isolated oculogyric spasm in clopenthixol and perphenazine therapy].
Topics: Adult; Clopenthixol; Eye Diseases; Female; Humans; Male; Perphenazine; Piperazines; Schizophrenia; Spasm; Tranquilizing Agents; Xanthenes | 1968 |
[Clinical and EEG study (polygraph recording) of a new neuroleptic drug: Sordinol (clopenthixol)].
Topics: Adult; Aged; Clopenthixol; Electroencephalography; Humans; Mental Disorders; Middle Aged; Schizophrenia; Tranquilizing Agents | 1965 |
[Clopenthixol in the treatment of psychoses. Preliminary clinical evaluation].
Topics: Adolescent; Adult; Aged; Clopenthixol; Humans; Middle Aged; Psychotic Disorders; Schizophrenia; Tranquilizing Agents | 1965 |
[Accidental hypothermia during treatment with a neuroleptic agent].
Topics: Adult; Body Temperature Regulation; Clopenthixol; Glycosuria; Humans; Hypoglycemia; Hypothermia; Male; Schizophrenia; Tranquilizing Agents | 1966 |